Welcome to Aetos Life Care. Looking for a reliable pharmaceutical manufacturer?

Lisinopril & Hydrochlorothiazide Tablet (10+12.5 mg)

Lisinopril & Hydrochlorothiazide Tablets combine an ACE inhibitor (Lisinopril) with a thiazide diuretic (Hydrochlorothiazide) for effective dual-action blood pressure control. Lisinopril relaxes blood vessels by inhibiting the angiotensin-converting enzyme, while Hydrochlorothiazide promotes diuresis, reducing blood volume and pressure. This fixed-dose combination is clinically proven to improve compliance in patients with moderate to severe hypertension.

Enquiry Now

Description

Indications:

  • Essential (primary) hypertension
  • Hypertension not adequately controlled by monotherapy
  • Cardiovascular risk reduction in hypertensive patients

Key Features:

  • Fixed-dose combination for synergistic blood pressure control
  • ALU-ALU blister offers maximum protection against humidity and oxidation
  • Reduces pill burden, enhancing patient compliance
  • Produced in WHO-GMP certified plants adhering to stringent international standards

Export & Market Positioning:

Trusted by distributors, hospitals, and government institutions globally, Aetos Life Care’s Lisinopril & Hydrochlorothiazide Tablets are supplied to regulated and semi-regulated markets, including Africa, Latin America, Southeast Asia, and CIS nations. Our product is supported by a complete regulatory dossier, COAs, stability data, and customized packaging.

Contract Manufacturing Services:

We offer third-party contract manufacturing under client-owned brands, including full regulatory support, region-specific artwork, and competitive bulk pricing. This product is available for private labeling and long-term partnership contracts.

Storage Conditions:

Store in a cool, dry place below 25°C. Protect from moisture and sunlight. Keep out of reach of children.

Leading Manufacturer and Exporter of Pharmaceuticals Across Continents

Aetos Life Care is a trusted manufacturer and exporter of high-quality generic and specialty medicines, serving over 40 countries across Latin America, Africa, Asia, Europe, and the CIS region. We have a strong presence in key markets, including Iraq, Jordan, Saudi Arabia, UAE, Ukraine, Kazakhstan, Venezuela, Ecuador, and more. Backed by 15 WHO-GMP accredited facilities designed to meet EU-GMP standards, we ensure the highest quality, safety, and compliance in every product we deliver.

Iraq, Jordan, Riyadh (Saudi Arabia), Dubai (UAE)

Ukraine, Kazakhstan, Turkmenistan, Tajikistan

Venezuela, Ecuador, Peru, Paraguay, Panama, Costa Rica, El Salvador

Cameroon, South Sudan, Angola

Myanmar